Periodic paralysis is a group of rare genetic disorders that cause episodes of muscle weakness or full paralysis, lasting anywhere from minutes to days. These episodes come and go, which is why the condition is called “periodic.” The underlying problem lies in faulty ion channels in muscle cells, caused by inherited gene mutations that disrupt the electrical signals muscles need to contract.
There are three primary types: hypokalemic periodic paralysis, hyperkalemic periodic paralysis, and Andersen-Tawil syndrome. Each involves different genes and slightly different triggers, but they share a core feature: sudden, temporary episodes of flaccid weakness that can range from mild heaviness in the limbs to complete inability to move.
How Ion Channels Cause Muscle Failure
Your muscles contract when electrical signals travel along the surface of each muscle fiber. Those signals depend on a precise voltage difference across the cell membrane, normally between negative 85 and negative 95 millivolts. In periodic paralysis, mutations in the genes that build sodium, calcium, or potassium channels cause the resting voltage to become unstable.
During an attack, the membrane voltage shifts to an abnormally shallow level (around negative 45 to negative 60 millivolts). At that level, the sodium channels that would normally fire an electrical impulse become stuck in an inactive state, with their availability dropping to 50% or less of normal. The muscle fiber essentially locks itself out of contracting. It’s the same principle behind certain surgical muscle relaxants: the membrane is so depolarized that no new signal can propagate, and the muscle goes limp.
Almost all mutations responsible for the hypokalemic form occur at very specific spots on the channel protein, where they create a tiny, abnormal leak of sodium ions through what’s called the “gating pore.” This leak pathway isn’t the channel’s normal pore. Instead, the mutation opens an unintended gap in the voltage-sensing part of the channel, gradually destabilizing the membrane until it tips into that paralyzed state.
Hypokalemic Periodic Paralysis
This is the most common form. Attacks are associated with drops in blood potassium, typically below 3.0 mmol/L (the normal range is roughly 3.5 to 5.0). The potassium isn’t lost from the body. It shifts from the bloodstream into muscle cells, which is what triggers the abnormal depolarization.
The two most reliable triggers are rest after strenuous exercise and carbohydrate-heavy meals. Eating a large plate of pasta or rice, for instance, stimulates insulin release, which drives potassium into cells. Other triggers include emotional stress, cold temperatures, high sodium intake, alcohol, and certain medications like corticosteroids. Episodes typically strike hours after the trigger, often in the middle of the night or early morning. Weakness can be localized to one limb or affect the whole body, and attacks last from several hours to days.
About 70% to 80% of people with this form carry mutations in the gene for a calcium channel (CACNA1S), while roughly 10% have mutations in a sodium channel gene (SCN4A). The remaining cases may involve genes not yet identified.
Hyperkalemic Periodic Paralysis
In this form, attacks are associated with elevated or normal-to-high potassium levels rather than low ones. Onset is earlier: about half of affected individuals have their first attack in the first decade of life, and 25% report their first episode by age ten. A typical attack begins in the morning before breakfast, lasts 15 minutes to an hour, and resolves on its own. In about 20% of cases, though, episodes stretch beyond two days and can last more than a week.
Attack frequency varies enormously. Some people experience daily episodes, others go months between attacks. The pattern generally worsens through adolescence and adulthood, peaking around age 50 before gradually declining. Triggers include fasting, potassium-rich foods, rest after exercise, and cold exposure.
A related condition called paramyotonia congenita overlaps significantly with hyperkalemic periodic paralysis. People with paramyotonia experience muscle stiffness (myotonia) that worsens with cold and with repeated use, the opposite of typical myotonia, which improves with activity.
Andersen-Tawil Syndrome
Andersen-Tawil syndrome stands apart because it affects more than just skeletal muscle. It’s defined by a triad of three features: episodes of periodic paralysis, heart rhythm abnormalities, and distinctive physical characteristics. Not everyone has all three, but a diagnosis is suspected when at least two are present.
The cardiac component includes prolonged QT intervals and ventricular arrhythmias, meaning the electrical system of the heart is also disrupted by the faulty ion channel. The physical features are subtle and variable: low-set ears, widely spaced eyes, a small jaw, curved pinky fingers (clinodactyly), webbing between toes, short stature, and scoliosis. The condition is caused by mutations in KCNJ2, which encodes a potassium channel expressed in both muscle and heart tissue.
What an Attack Feels Like
People often describe a heavy, leaden feeling in their muscles as an attack builds. Weakness can be focal, affecting just the legs or arms, or generalized. During a severe episode, you may be unable to stand, walk, or even lift your arms. Breathing muscles are rarely affected, but it can happen in extreme cases. The paralysis is “flaccid,” meaning the muscles are limp rather than stiff. Reflexes in the affected limbs disappear during an attack and return as strength recovers.
Between episodes, many people feel completely normal, especially early in the disease. Over years, however, some develop a fixed, permanent weakness that doesn’t resolve between attacks. This progressive myopathy is one of the more concerning long-term consequences and can significantly affect quality of life.
How It’s Diagnosed
Diagnosis starts with a clinical history: recurrent episodes of weakness with spontaneous recovery, a family history consistent with autosomal dominant inheritance (meaning one copy of the mutated gene from either parent is enough to cause the condition), and identifiable triggers. Blood potassium measured during an attack can point toward the hypokalemic or hyperkalemic type.
A specialized nerve conduction study called the long exercise test helps confirm the diagnosis. In this test, a nerve in the hand is stimulated while the muscle’s electrical response is recorded at baseline, during five minutes of exercise, and for 50 minutes afterward. A drop of more than 40% in the electrical signal after exercise is considered a positive result, reflecting the abnormal membrane behavior characteristic of periodic paralysis.
Genetic testing provides definitive confirmation and can identify the specific mutation, which sometimes influences treatment choices. However, not all patients have an identifiable mutation with current testing panels.
Managing and Preventing Attacks
Treatment focuses on two goals: stopping acute attacks and reducing how often they happen.
For hypokalemic attacks, oral potassium supplements are the first-line treatment. Potassium given by mouth is preferred over intravenous delivery because IV potassium carries a risk of dangerous rebound effects. Sugar-containing solutions (like dextrose) and high-sodium fluids can actually worsen an attack, so they’re avoided.
For hyperkalemic attacks, strategies aim to lower potassium or prevent its rise. Light exercise at the onset of symptoms, eating something carbohydrate-rich, or inhaling a short-acting bronchodilator (which pushes potassium back into cells) can sometimes abort a mild episode.
Long-Term Prevention
Carbonic anhydrase inhibitors are the main class of medication used to prevent attacks in both forms. The most well-known is acetazolamide, which has been used for decades despite no formal consensus guidelines for its use. A newer option, dichlorphenamide, received FDA approval in 2015 based on randomized controlled trials showing it reduced attack frequency compared to placebo. Both medications work partly by creating a mild metabolic acidosis, which helps stabilize the muscle membrane.
Response to these medications varies and can depend on genotype. Some patients with sodium channel mutations respond poorly to acetazolamide or even worsen on it, making genetic testing practically useful rather than purely academic.
Dietary and Lifestyle Strategies
Diet plays a meaningful role in attack prevention, and the recommendations differ by type. For hypokalemic periodic paralysis, reducing carbohydrate and sodium intake helps minimize the insulin-driven potassium shifts that trigger episodes. Potassium-rich foods like bananas, potatoes, and leafy greens can help maintain stable levels. For hyperkalemic periodic paralysis, the approach is roughly the opposite: avoiding potassium-rich foods and eating smaller, more frequent meals that include moderate carbohydrates.
For both types, avoiding known personal triggers matters enormously. Keeping a log of what preceded each attack helps identify patterns. Common lifestyle adjustments include avoiding intense exercise followed by complete rest (gentle cool-downs help), keeping warm in cold environments, managing stress, and avoiding alcohol. Because the condition is inherited with autosomal dominant transmission, each child of an affected parent has a 50% chance of inheriting the mutation.